Sunday, August 16, 2026
Maspalomas 24h | Newspaper of Maspalomas and Southern Gran Canaria
Bioever Clinic launches the first Executive Longevity Program in the Canary Islands

Bioever Clinic launches the first Executive Longevity Program in the Canary Islands

Maspalomas24h Friday, July 17, 2026

A pioneering initiative that applies precision medicine to measure, protect, and optimize the physical, mental, and cognitive performance of business leaders, executives, and high-level professionals. Because a company's greatest competitive advantage still depends on the people who lead it.

 

Over the past few years, companies have invested millions in artificial intelligence, digital transformation, automation, and talent development. Technology is advancing at an unprecedented pace and is redefining how we work, compete, and grow.

 

[Img # 23876]

 

However, while organizations seek to become more efficient, there is one question that is only now beginning to take its place in business strategy:

 

Who is taking care of the people who will have to make the most important decisions over the next ten or twenty years?

 

With this vision, Clínica Bioever created the Executive Longevity Program , the first of its kind in the Canary Islands specifically designed for business owners, executives, and high-level professionals. Its objective is not to treat illnesses, but to preserve what most influences a leader's performance: their energy, mental clarity, ability to concentrate, physical resilience, and potential to continue making high-impact decisions for years to come.

 

This is not a conventional medical examination.

 

The aim is to understand how the body is actually functioning in order to identify early on the factors that limit performance and to design a personalized plan that allows it to be optimized before wear and tear takes its toll.

 

Because biological deterioration doesn't begin when a disease appears. It begins much earlier.

 

Poor sleep, chronic stress, muscle loss, silent inflammation, and metabolic disorders not only increase the risk of future illness, but also reduce energy, concentration, resilience, and decision-making quality.

 

The person continues working, continues leading, and continues taking on responsibilities. But they no longer do so at the same level of performance. And this silent decline has a cost that is rarely reflected in a profit and loss statement.

 

The company measures everything... except the asset that underpins all its results.

 

Organizations analyze sales, profitability, productivity, costs, and return on investment with extraordinary precision. However, few know the true operational status of those who make those results possible.

 

For decades we have understood health as a strictly personal matter. Today, precision medicine demonstrates that it can also become a strategic tool for businesses.

 

Through advanced biomarkers, body composition studies, neurocognitive assessment, cardiorespiratory capacity and other functional indicators, it is possible to detect which factors are compromising performance long before a disease appears.

 

From human capital to biological capital

 

For years we have talked about financial capital, technological capital, and human capital.

 

Now a concept is beginning to emerge that will likely shape the next decade: biological capital.

 

It is the physical, mental, and cognitive capacity that allows a person to sustain a high level of performance continuously. Companies of the future will not only compete to attract talent, but also to retain that talent under the best possible conditions.

 

Because the real cost doesn't begin when an executive gets sick. It begins much earlier, when their energy, mental clarity, leadership skills, and cognitive performance gradually decline.

 

Bioever introduces Executive Longevity in the Canary Islands

 

Bioever Clinic has developed the first Executive Longevity Program in the Canary Islands , bringing precision medicine to the business environment.

 

The program is designed to IDENTIFY and CORRECT early on those factors that most compromise the performance of an executive : persistent fatigue, decreased ability to concentrate, chronic stress, low recovery capacity, metabolic alterations, loss of muscle mass and other silent biological processes that limit leadership long before an illness appears.

 

Based on a comprehensive assessment of biological capital, a fully personalized plan is designed that combines advanced medical evaluation, biomarkers, neurocognition, body composition, cardiorespiratory capacity, nutrition, exercise, hormonal optimization when indicated, and precision medicine strategies tailored to each individual. 

 

It's not just about living longer. It's about leading better for longer.

 

Beyond the program itself, what is truly important is the trend it represents.

 

Twenty years ago, it seemed unthinkable that digital transformation would occupy a priority place in any board of directors. Today, no one questions it.

 

It's possible that the same thing will happen with Executive Longevity within a decade . Because artificial intelligence will continue to transform the way we work. But no technology will be able to replace the mental clarity of a well-rested leader, the resilience of a healthy body, or the ability to consistently make sound decisions.

 

The next competitive advantage will not only consist of having better tools, but of having leaders who are biologically prepared to take advantage of them.

 

[Img # 23877]

With your registered account

Write your email and we will send you a link to write a new password.